Inventor · disambiguated record
Michael Simeone
Also filed as: SIMEONE MICHAEL
3 granted patents·1 pending application·8 citations·filing 2017–2022
67Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC4
Top patents by PatentIndex Score
4 records- 0189US11718591B2Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 8, 2023·1 cites·20 claims
- 0287US10100021B2Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Oct 16, 2018·4 cites·24 claims
- 0386US10752599B2Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Aug 25, 2020·3 cites·20 claims
- 0449US2022306626A1Crystalline form of a dihydrochloride salt of a jak inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →